medical education

Implementation Blueprint for Omnichannel Education

The Ultimate Guide to Omnichannel Education

CEO Parth Khanna’s Interview with Dr. Bertalan Mesko from The Medical Futurist, on Life Sciences Education

How Life Sciences Companies Can Level Up Healthcare Education in Post-COVID Era

ACTO Integrates Life Sciences Education Platform with Veeva CRM

New Era; New Launch Excellence Blueprint for 2021-2022

What Does ACTO’s Acquisition of CoHealth Mean for Patient Education?

ACTO Acquires CoHealth to Open New Frontier in Patient Education

The Omnichannel Learning Journey with Parth Khanna

ACTO Earns Gold at Brandon Hall Technology Awards 2021

Critical Insights from Industry Leaders for Successful Implementation of Commercial Digital Transformation

ACTO Kicks Off 2021 with Chart-Topping Growth

ACTO Closes $11.5M Series A Round to Accelerate Virtual Transformation for Life Sciences Companies

ACTO Emerges as a Leader in Life Sciences Commercialization; Closes Strong Calendar Year 2018 with 184% Revenue Growth and Doubled Customer Base

Omnichannel Education For The Life Sciences

Life Sciences’ Transformative Journey to Consolidation in 2021 and What to Expect in 2022

How Chatbots Can Help Us Beat COVID-19

The Need for Rapid Reskilling in an Ever-changing Landscape

Global Leader in Omnichannel Education Certified as a Great Place to Work® in Canada for the Second Consecutive Year

ACTO Acquires Scrimmage, Disrupting Life Sciences Learning and Engagement Market

Exclusive ACTO Omnichannel Platform Mini Demo

Episode 7: How is Technology Reshaping the Medical Device Industry?

Episode 8: Omnichannel Education – The Future of Life Sciences

Digital Transformation Ideals of Change – Prescription for Pharma and Medical Device Trainers for Rapid Reskilling

ACTO Acquires Scrimmage

ACTO Wins Gold Stevie® Award in the Cloud Platform Category in 2019 International Business Awards

Fighting the Forgetting Curve: The Life Sciences Trainer’s Guide to Microlearning

New Era; New Launch Excellence Blueprint for 2021-2022

John Constantine, Senior VP at Orchestrall, Inc: How to Accelerate Drug and Device Launch in the Post-COVID World

When the Rubber Meets the Road, Don’t Slip

Rapid Reskilling in an Ever-Changing Landscape

ACTO Achieves 158% Year to Date Revenue Growth in 2019 and Has Digitally Transformed Over 50 Life Sciences Companies

ACTO Named One of the 2019 PM360 ELITE 100

For Our Customers: COVID-19 Response Series

Episode 1: Tailoring Your Clinical and Brand Story with Integrity

Episode 6: Pharma Sales – Today versus Tomorrow

New Era; New Launch Excellence Blueprint for 2021-2022

Episode 2: How to Accelerate Drug and Device Launch in the Post-COVID World